Pharmacotherapy of erectile dysfunction: focus on cardiovascular safety.
about
Sexual function in hypertensive patients receiving treatmentSildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial K(ATP) channels when administered at reperfusion following ischemia in rabbitsMolecular and functional characterization of Kv 7 channels in penile arteries and corpus cavernosum of healthy and metabolic syndrome rats.Phosphodiesterase 5 inhibitors: are they cardioprotective?The evaluation of apomorphine for the treatment of erectile dysfunction.Comment: acute myocardial infarction after sildenafil citrate ingestion.
P2860
Pharmacotherapy of erectile dysfunction: focus on cardiovascular safety.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Pharmacotherapy of erectile dysfunction: focus on cardiovascular safety.
@ast
Pharmacotherapy of erectile dysfunction: focus on cardiovascular safety.
@en
type
label
Pharmacotherapy of erectile dysfunction: focus on cardiovascular safety.
@ast
Pharmacotherapy of erectile dysfunction: focus on cardiovascular safety.
@en
prefLabel
Pharmacotherapy of erectile dysfunction: focus on cardiovascular safety.
@ast
Pharmacotherapy of erectile dysfunction: focus on cardiovascular safety.
@en
P2860
P356
P1476
Pharmacotherapy of erectile dysfunction: focus on cardiovascular safety.
@en
P2093
Robert A Kloner
Thorsten Reffelmann
P2860
P304
P356
10.1517/14740338.4.3.531
P407
P577
2005-05-01T00:00:00Z